Department of Management
Glaxo Smith Kline
Mullen-Sheri is Vice President, Immunology and Rare Disease. Sheri has led GSK’s Immunology and Rare Disease business in the US since 2010 when she was appointed to build this new specialty business. Sheri has 25 years of commercial experience. She joined GSK in 1990 as a sales representative and held various positions of increasing responsibility in Sales, Marketing, and Operations. Prior to heading the Immunology and Rare Disease team, Sheri was the Vice President of Sales for Oncology.